Assessing Becton Dickinson (BDX) Valuation After Recent Share Moves And Business Separation Plans [Yahoo! Finance]
Becton, Dickinson and Company (BDX)
Last becton, dickinson and company earnings: 2/6 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
investors.bd.com
Company Research
Source: Yahoo! Finance
week, month and past three months, prompting investors to reassess the medical supplier. See our latest analysis for Becton Dickinson. At a share price of $201.52, Becton Dickinson's recent 7.9% 90 day share price return contrasts with a 12.7% decline in 1 year total shareholder return. This suggests shorter term momentum while longer term returns remain under pressure. If Becton Dickinson's recent moves have you reassessing healthcare exposure, it could be a useful moment to scan other healthcare stocks that fit your preferences and risk profile. With Becton Dickinson trading at $201.52, sitting close to analyst targets yet flagged with a wide estimated intrinsic discount, the key question is whether the market is overlooking value here or already pricing in future growth? Using a fair value estimate of about $205 per share versus the last close at $201.52, the most followed narrative sees Becton Dickinson as modestly mispriced rather than dramatically out of line. The pe
Show less
Read more
Impact Snapshot
Event Time:
BDX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BDX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BDX alerts
High impacting Becton, Dickinson and Company news events
Weekly update
A roundup of the hottest topics
BDX
News
- BD Receives FDA 510(k) Clearance for EnCor EnCompass™ Breast Biopsy and Tissue Removal SystemPR Newswire
- Becton, Dickinson And Company: Rightfully Re-Rated (Downgrade) [Seeking Alpha]Seeking Alpha
- BD Names Shawn Bevec as Senior Vice President of Investor RelationsPR Newswire
- Is Becton Dickinson (BDX) Pricing Reflect Its Recent Multi-Year Share Price Declines [Yahoo! Finance]Yahoo! Finance
- Waters Corporation expands into biosciences and diagnostics [Yahoo! Finance]Yahoo! Finance
BDX
Earnings
- 11/6/25 - Beat
BDX
Sec Filings
- 1/6/26 - Form 8-K
- 1/6/26 - Form 4
- 12/29/25 - Form 144
- BDX's page on the SEC website